Targeted photodynamic therapy of breast cancer cells using antibody–phthalocyanine–gold nanoparticle conjugates

Tanya Stuchinskaya, Miguel Moreno, Michael J. Cook, Dylan R. Edwards, David A. Russell

Research output: Contribution to journalArticlepeer-review

309 Citations (Scopus)
22 Downloads (Pure)


A 4-component antibody-phthalocyanine-polyethylene glycol-gold nanoparticle conjugate is described for use as a potential drug for targeted photodynamic cancer therapy. Gold nanoparticles (4 nm) were stabilised with a self-assembled layer of a zinc-phthalocyanine derivative (photosensitiser) and a heterobifunctional polyethylene glycol. Anti-HER2 monoclonal antibodies were covalently bound to the nanoparticles via a terminal carboxy moiety on the polyethylene glycol. The nanoparticle conjugates were stable towards aggregation, and under irradiation with visible red light efficiently produced cytotoxic singlet oxygen. Cellular experiments demonstrated that the nanoparticle conjugates selectively target breast cancer cells that overexpress the HER2 epidermal growth factor cell surface receptor, and that they are effective photodynamic therapy agents.
Original languageEnglish
Pages (from-to)822-831
Number of pages10
JournalPhotochemical & Photobiological Sciences
Issue number5
Publication statusPublished - May 2011

Cite this